A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC)

Clinical trial NCT04779307 · COMPLETED

Trial details

NCT number: NCT04779307
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Colitis, Ulcerative

Start date: 2021-10-19
Primary completion: 2025-07-01
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.